Physicians and health care practitioners using OSCAR Pro are now able to easily create, renew and cancel prescriptions electronically, while improving overall patient care through secure clinician messaging. WELL is offering an end-to-end solution from virtual and on-site patient consultation to electronic prescription, resulting in a better physician and patient experience. By partnering with PrescribeIT®, health care practitioners, pharmacists and patients can have confidence that the solution ensures patient privacy and security of information.
“We are very excited to launch our e-prescribing service with Infoway’s PrescribeIT®,” said Hamed Shahbazi, Chairman and CEO of WELL. “Electronic prescriptions will be a key for making virtual visits more efficient and effective, and this integration with the WELL EMR network can help create a better patient experience. I am very proud of our WELL EMR Group who has worked tirelessly to successfully achieve conformance approval from Infoway and our WELL Digital Health Apps team who have made the service available through the apps.health marketplace.”
PrescribeIT® enhances clinical communications, e-renewals, privacy and security. Prescriptions can now be sent directly from within OSCAR Pro EMR in a secure electronic format to the patient's pharmacy of choice and pharmacies can electronically request prescription renewals from the patient's health care provider. Electronic prescriptions are key for virtual visits as the patient does not have to rely on faxing prescriptions to pharmacies. Furthermore, patient safety is increased due to prevention of data entry errors at the pharmacy and prescription fraud is decreased through direct transmission of the prescription from the prescriber to the pharmacy through the PrescribeIT® service.
“We are excited about this partnership with WELL to make PrescribeIT® available to prescribers who use the OSCAR Pro EMR software,” said Jamie Bruce, Executive Vice President, Infoway. “PrescribeIT® makes prescribing safer, more secure, easier and more convenient. PrescribeIT® is also an increasingly important tool in the prescriber’s virtual care toolbox.”
WELL HEALTH TECHNOLOGIES CORP.
Per: “Hamed Shahbazi”
Chief Executive Officer, Chairman and Director
WELL is an omni-channel digital health company whose overarching objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health. As such, WELL owns and operates 25 primary health care clinics, is Canada's third largest digital Electronic Medical Records (EMR) supplier serving over 2,000 medical clinics, operates a leading national telehealth service and is a provider of digital health, billing and cybersecurity related technology solutions. WELL is an acquisitive company that follows a disciplined and accretive capital allocation strategy. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and the Company was recognized as a TSX Venture 50 Company three years in a row in 2018, 2019 and 2020. To access the Company's telehealth service, visit: tiahealth.com or virtualclinics.ca and for corporate information, visit: www.well.company.
About Canada Health Infoway
Infoway helps to improve the health of Canadians by working with partners to accelerate the development, adoption and effective use of digital health across Canada. Through our investments, we help deliver better quality and access to care and more efficient delivery of health services for patients and clinicians. Infoway is an independent, not-for-profit organization funded by the federal government. Visit www.infoway-inforoute.ca.
Canada Health Infoway is working with Health Canada, the provinces and territories, and industry stakeholders to develop, operate and maintain the national e-prescribing service known as PrescribeIT®. PrescribeIT® will serve all Canadians, pharmacies and prescribers and provide safer and more effective medication management by enabling prescribers to transmit a prescription electronically between a prescriber’s electronic medical record (EMR) and the pharmacy management system (PMS) of a patient’s pharmacy of choice. PrescribeIT® will protect Canadians’ personal health information from being sold or used for commercial activities. Visit www.PrescribeIT.ca.
This news release may contain "forward-looking statements" within the meaning of applicable Canadian securities laws, including, without limitation statements regarding: improvement to overall patient care through clinical messaging; and the belief that the launch will ensure patient privacy and security of information. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties, and contingencies. These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “will”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause future results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. WELL’s statements expressed or implied by these forward-looking statements are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL 's control, and undue reliance should not be placed on such statements. Forward-looking statements are qualified in their entirety by inherent risks and uncertainties, including: risks related to privacy and cyber security concerns; risks related to compatibility between the two platforms and solutions; and error free adoption, use and growth of the service. Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise.
Neither the TSX nor its Regulation Services Provider (as that term is defined in policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.
For further information:
Pardeep S. Sangha
VP Corporate Strategy and Investor Relations
WELL Health Technologies Corp.
Inquiries about PrescribeIT®